Evidence map›Paper›PMID 34495260›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2021

COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?

Luís Arthur Brasil Gadelha Farias, Lisandra Serra Damasceno, Silviane Praciano Bandeira, Francisca Kalline de Almeida Barreto, Terezinha do Menino Jesus Silva Leitão, Luciano Pamplona de Góes Cavalcanti

Abstract readLetterComment
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Miltefosine: A Repurposing Drug against Mucorales Pathogens.Journal of fungi (Basel, Switzerland) · 2023
    Article
  4. Article
  5. A fatal case of disseminated pulmonary and renal mucormycosis caused by Rhizopus microspores.Revista do Instituto de Medicina Tropical de Sao Paulo · 2023
    Article
  6. Article
  7. Resurgence of mucormycosis during COVID-19 pandemic.Oral and maxillofacial surgery cases · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Luís Arthur Brasil Gadelha FariasEscola de Saúde Pública do Ceará, Fortaleza, CE, Brasil.ORCID 0000-0002-8978-9903
Lisandra Serra DamascenoHospital São José de Doenças Infecciosas, Fortaleza, CE, Brasil.ORCID 0000-0003-1425-5912
Silviane Praciano BandeiraUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Patologia e Medicina Legal, Fortaleza, CE, Brasil.ORCID 0000-0002-4051-5645
Francisca Kalline de Almeida BarretoUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Saúde Comunitária, Fortaleza, CE, Brasil.ORCID 0000-0001-9767-7154
Terezinha do Menino Jesus Silva LeitãoHospital São José de Doenças Infecciosas, Fortaleza, CE, Brasil.ORCID 0000-0002-3301-3057
Luciano Pamplona de Góes CavalcantiUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Saúde Comunitária, Fortaleza, CE, Brasil.ORCID 0000-0002-3440-1182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19MucormycosisBrazilHumansSARS-CoV-2

Identifiers

PMID34495260
PMCPMC8437445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.